A new research project underway at Scripps Health will attempt to design and test a smart shoulder, one that could record and ...

Qiagen (QGEN) announced the U.S. regulatory clearance of the first in a series of QIAstat-Dx Gastrointestinal Panel tests for ...

The government is changing what foods can be branded as “healthy.” It expects basically no one to listen.

In the ‘80s, researchers set out to test a medication called sildenafil citrate for treating high blood pressure and angina ...

U.S. government report on “notorious markets” known for counterfeiting and other violations of intellectual property says ...

The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...

Biotech M&A is heating up, and Mirum Pharmaceuticals stands out. Discover why analysts predict a 50% upside and long-term ...

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

Withings' BPM Vision blood pressure monitor has a color screen, different cuff sizes, and the option to have a cardiologist ...

In recent years, more and more celebrities — like Elon Musk and Whoopi Goldberg — have spoken up about using GLP-1 ...

As the new year begins, change is afoot inside the Beltway as the 119th Congress gets underway and Washington prepares for President Trump’s ...

Allison L. Watkins is the CEO of Watkins-Conti, an American healthcare company that develops innovative and accessible solutions for women's pelvic health. She has two children and lives in Oklahoma.